Full text is available at the source.
Abstract
Patients who experienced severe COVID-19 showed lower microbial richness compared to those with mild disease.
- Probiotic intervention significantly improved microbial richness in patients after severe COVID-19.
- Reorganization of specific gut bacteria taxa was observed in severe COVID-19 patients but was not affected by probiotics.
- Serum lipoproteins were dysregulated in severe COVID-19 patients, with HDL and LDL components temporarily decreased in the probiotic group.
- Alterations in the stool metabolome included an increase in L-DOPA and butyrate after three and six months of probiotic intervention, respectively.
- Probiotics partially improved quality of life and modulated immune responses in patients recovering from severe COVID-19.
- Increased intestinal permeability at baseline in severe COVID-19 patients remained unchanged after the intervention.
Simplified